by Sowmya Viswanathan | Sep 6, 2018
In this month’s installment of the “Bioprocess and Bioanalytics” blog, we will hear from Drs. Robin Turner and James Piret on how an established spectroscopy method – Raman spectroscopy – can be utilized to tell us new information about cell therapy products. Both are...
by Sowmya Viswanathan | Jun 26, 2018
Debe Griffin, MSc, ASQ CPGP, has over 20 years of experience in the cell therapy field, both in bench positions and in leadership. Her primary interests are process improvement, quality assurance and regulatory affairs. She is a consultant with FACT Consulting...
by Sowmya Viswanathan | Jun 19, 2018
Debe Griffin, MSc, ASQ CPGP, has over 20 years of experience in the cell therapy field, both in bench positions and in leadership. Her primary interests are process improvement, quality assurance and regulatory affairs. She is a consultant with FACT Consulting...
by Sowmya Viswanathan | Mar 12, 2018
Dr. Sheng Lin-Gibson is the Chief of Biosystems and Biomaterials Division at the U.S. National Institute of Standards and Technology (NIST) and directs its Regenerative Medicine Programs. She serves as the Convenor of ISO/TC 276: Biotechnology Working Group...
by Sowmya Viswanathan | Jan 8, 2018
In this month’s blog on addressing specific bioprocess and bioanalytical challenges to develop Cell and Gene Therapies (CGTs), we hear from Dr. Nick Timmins on quantifying performance of CGTs using cell yield, and some of the methods to measure it, as a metric...
Comments